 |
INTRODUCTION |
THE POSSIBILITY OF USING
LIGHT to measure the oxygen saturation of hemoglobin in vivo has
been explored since the 1940s (37). The feasibility of
optical blood oximetry stems from the oxygenation dependence of the
optical spectrum of hemoglobin. This is illustrated in Fig.
1, which shows the absorption spectra of
100 µM hemoglobin for oxygen saturation values of 0, 20, 40, 60, 80, and 100%. The spectra of Fig. 1 were calculated from published values
of the molar extinction coefficients of oxyhemoglobin
(HbO2) and deoxyhemoglobin (Hb) (43, 53).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Near-infrared absorption spectra of 100 µM hemoglobin
concentration ([Hb-T], where T stands for total) for different values
of the oxygen saturation (SO2) in the range of
0-100%. The curve for SO2 = 0%
corresponds to the deoxyhemoglobin (Hb) absorption spectrum, whereas
the curve for SO2 = 100% corresponds to
the oxyhemoglobin (HbO2) absorption spectrum. These spectra
have been computed from published spectra of the molar extinction
coefficients of HbO2 and Hb (43, 53).
|
|
Oxygen saturation of the pulmonary capillary blood in rabbits has been
measured by using dynamic invasive techniques (48). Near-infrared light in the wavelength range from 700 to 900 nm results
in a sufficient penetration depth for the noninvasive optical
monitoring of skeletal muscle, cerebral gray matter, and breast tissue.
As a result, near-infrared techniques allow a noninvasive assessment of
hemoglobin saturation for a wide range of applications, such as the
study of muscle metabolism (7, 9, 12, 29, 45), the
diagnosis of vascular disorders (2, 20, 32, 33, 44, 49),
functional brain imaging (3, 10, 24, 30, 35, 50), and
breast cancer detection (23, 28, 40, 42, 46).
If near-infrared light is highly sensitive to the oxygen saturation of
hemoglobin, then its large penetration depth inside tissues implies
that the arterial, venous, and capillary compartments all contribute to
the optical signal. The average hemoglobin oxygenation measured
with near-infrared spectroscopy (NIRS) (19, 34, 41) is usually referred to as tissue oxygen saturation
(StO2). StO2 values are
assumed to be in between arterial and local venous saturation values
(SaO2 and SvO2, respectively). A
number of research studies have investigated the relationship between
the near-infrared (noninvasive) measurement of
StO2 and the values of SaO2
and local SvO2 measured invasively from drawn blood
samples (31, 51). The contribution of the arterial
compartment to the noninvasive optical signal can be isolated because
of its unique temporal dynamics associated with the systolic-diastolic
blood pressure variation at the heartbeat frequency (1).
The pulsatile component of the optical signals at two or more
wavelengths at the heartbeat frequency is used by conventional
(1, 36) or self-calibrated (21) pulse
oximeters to measure the SaO2. SaO2
is a parameter that provides information about the ventilation and the
oxygen exchange in the lungs. In contrast, SvO2 is a
parameter that reflects the local balance between blood flow and oxygen
consumption. The noninvasive optical measurement of
SvO2 is complicated by the fact that the isolation of
the contribution of the venous compartment to the noninvasive optical
signal is not straightforward. There are no clinical devices presently
capable of monitoring SvO2 noninvasively.
A number of experimental approaches have been proposed to measure
SvO2 from induced local changes in the venous blood
volume. For instance, proposed approaches involve a venous occlusion in a limb (13, 39, 55, 56), tilting the patient's head down by 15 degrees (47), a partial jugular vein occlusion
(15, 54), or mechanical ventilation (52). In
all these approaches, SvO2 is optically measured as
the ratio between the increases in the HbO2 concentration
([HbO2]) and the total hemoglobin concentration (equal to
[HbO2] + [Hb], where [Hb] is deoxyhemoglobin
concentration) induced by the local increase in venous blood volume. To
overcome the limitations of these methods, which can either be applied only to the limbs (venous occlusion method) or require an external perturbation (partial jugular vein occlusion, mechanical ventilation, and tilting methods), we propose an alternative approach that is an
extension of the method of Wolf et al. (52). This approach involves no external perturbations and is applicable to subjects who
are breathing either spontaneously or synchronously with a metronome
set at their average respiratory frequency. Furthermore, this method
can provide continuous and real-time monitoring of SvO2. The basic idea is to measure
SvO2 from the amplitude of the optically measured
[HbO2] and [Hb] oscillations at the respiratory frequency. The basic hypothesis, originally formulated in this context
and tested on the brain of mechanically ventilated infants by Wolf et
al., is that the oscillatory components of [HbO2] and [Hb] at the breathing rate are mostly representative of the venous compartment. Because the venous compliance is ~20 times as large as
the arterial compliance (4), a given change in the blood pressure in the veins causes a venous volume change ~20 times as
large as the arterial volume change corresponding to the same pressure
change in the arteries. During normal breathing, the inspiration phase
involves a decrease in the intrathoracic pressure and an increased
pressure gradient between the peripheral venous system and the
intrathoracic veins. This causes blood to be drawn from the
extrathoracic veins into the intrathoracic vessels and heart
(26). Because of the vein valves, venous return is
increased more by inspiration than it is decreased by expiration
(38). The net effect is the so-called respiratory pump
that facilitates the venous return from the periphery by the
respiration-induced periodic fluctuations in the central venous
pressure (38). As a result of the respiratory pump, the
peripheral venous blood volume oscillates at the respiratory frequency,
decreasing during inspiration and increasing during expiration.
It is on this oscillatory component at the respiratory frequency that
we base our near-infrared measurement of the SvO2. We coin the term spiroximeter to indicate an instrument for measuring the
SvO2 from respiration-induced oscillations in the
venous blood pressure and in the venous volume fraction in tissues. It
must be observed that respiration may also induce perturbations to the
heart rate (respiratory sinus arrhythmia) and consequently to the
cardiac output and arterial blood pressure. As a result, the arterial
compartment volume may, in general, also oscillate at the respiratory
frequency; thus near-infrared spiroximetry data must be carefully
examined to guarantee a reliable reading of SvO2.
We report a validation study conducted on the hind leg of three
piglets, in which we compared the near-infrared measurements of
SvO2 (SvO2-NIRS) with the
SvO2 values obtained by the gas analysis of venous
blood samples (SvO2-blood). To show the applicability of spiroximetry to human subjects, we also conducted a preliminary test
on the vastus medialis and vastus lateralis muscles of healthy volunteers at rest and postexercise.
 |
MATERIALS AND METHODS |
Tissue spectrometer.
The near-infrared measurements were performed with a frequency-domain
tissue spectrometer (model 96208, ISS, Champaign, IL) (18,
25). This instrument uses two parallel photomultiplier tube
detectors that are time shared by eight multiplexed laser diodes
emitting at 636, 675, 691, 752, 780, 788, 830, and 840 nm,
respectively. The frequency of intensity modulation is 110 MHz, and
heterodyne detection is performed with a cross-correlation frequency of
5 kHz. The multiplexing rate, i.e., the frequency of sequential laser
switching, is 100 Hz. As a result, 50 cross-correlation periods are
acquired during the on time of each laser diode, and a complete
acquisition cycle over the eight wavelengths is completed every 80 ms.
The laser diodes and the photomultiplier tubes are all coupled to fiber
optics. The eight individual illumination fibers, each 400 µm in
internal diameter, are arranged into a fiber bundle having a
rectangular cross-section of 3.5 × 2.0 mm2. The
collecting circular fiber bundles are 3.0 mm in internal diameter. The
optical fibers are placed in contact with the skin by means of a
flexible plastic probe. The optical probe arranges the tips of the
illuminating and collecting fiber bundles along a line, with the two
collecting fiber bundles at distances of 1.0 and 2.0 cm from the single
illuminating bundle. In some cases, we have used a second tissue
spectrometer to perform simultaneous measurements on both legs
(piglets 2 and 3) or at different locations on
the same leg (human subjects). In the second tissue spectrometer (which
used the optical probes PL and HVL defined
below), the 840-nm laser diode was replaced by a laser diode emitting
at 814 nm.
Measurements on piglets.
We performed measurements on three piglets that were 15 ± 1 days
old and weighed 5 ± 1 kg. The experimental arrangement for the
piglet measurements is schematically illustrated in Fig.
2. The piglets were anesthetized by
inhalation of 3-4% isoflurane administered by means of a
breathing mask applied to the piglet's snout. The animals were not
mechanically ventilated, and they breathed freely throughout the
experiment. A strain-gauge belt (Sleepmate/Newlife Technologies,
Resp-EZ) was placed around the piglet's thorax to continuously monitor
the respiratory excursion. A pulse oximeter (Nellcor, N-200)
continuously recorded the heart rate at the foot of the right hind leg.
The analog outputs from the strain gauge and the pulse oximeter were
fed to the auxiliary input ports of the tissue spectrometer for
continuous coregistration of optical and physiological data. A femoral
cutdown was performed into the left inferior femoral vein to insert a
catheter for periodic blood sampling. The femoral venous blood samples
were run through a commercial blood-gas analyzer (Instrumentation
Laboratory, model 1304 pH/blood-gas analyzer) to obtain invasive
readings of SvO2-blood. One optical probe (identified
as probe PR) was always located on the right
(noncatheterized) hind leg. In piglets 2 and 3, a second probe (probe PL) was placed on the catheterized
(left) leg. The protocol consisted of varying the femoral
SvO2 over the approximate range of 20-95% by
modulating the volume fraction of oxygen inspired by the piglet
(FIO2) over the range of 10-100%. The oxygenation cycles performed on the three piglets are illustrated in Fig. 3. Each cycle consisted of
varying the FIO2 approximately every
4-6 min through the values of ~40, 15, 10, and 100%
(piglets 1 and 2) or ~40, 20, 17.5, 15, 12.5, 10, and 100% (piglet 3). We performed two
FIO2 cycles on piglet 1, four
on piglet 2, and three on piglet 3. For each
specific value of FIO2, we acquired about
3,000 optical data points [4 min × (60 s/min)/(80 ms/data point)] or more. During cycles C and D on
piglet 2, the optical probe PR was slightly moved
with respect to the location examined during cycles A and
B, to collect data on two different muscle volumes during
the two cycle pairs A-B and C-D. Optical
probe PR always collected data on the right hind leg,
whereas probe PL was placed on the left hind leg during
cycles A and B of piglet 2 and
cycles A and B of piglet 3 (we did not
collect data with the optical probe PL on piglet
1, during cycles C-D on piglet 2, and during
cycle C on piglet 3). In all three piglets, the invasive measurement of SvO2 from a femoral vein blood
sample was performed at the end of each
FIO2 interval, as shown in Fig. 3. Motion
artifacts were minimized in the optical data by securing the piglet's
legs to the operating table. The protocol was approved by the
Institutional Review Board of the Massachusetts General Hospital, where
the piglet experiments were performed.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Experimental arrangement for the piglet study. A
breathing mask applied to the piglet's snout provided the 3-4%
isoflurane anesthetic and was connected to the oxygen line for
variations in the fraction of inspired oxygen
(FIO2). A strain-gauge belt and a pulse
oximeter monitored the respiratory excursion and the heart rate,
respectively, and their analog outputs were directed to the auxiliary
inputs of the frequency-domain tissue spectrometer (ISS, Champaign, IL,
model 96208). One or two optical probes (PR on the right hind leg and
PL on the left hind leg) of the tissue spectrometer were used to
measure the near-infrared tissue absorption with a time resolution of
80 ms. The absorption oscillations at the respiratory frequency were
processed to provide measurement of the venous O2
saturation (SvO2-NIRSresp) (NIRS is
near-infrared spectroscopy). Invasive measurements of the venous
O2 saturation (designated SvO2-blood) were
obtained by gas analysis of venous blood samples collected by a femoral
vein catheter. aux, Auxiliary; optical I/O, optical
input/output.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Schematic representation of FIO2
cycles for piglet 1 (A), piglet 2 (B), and piglet 3 (C).
, Time at which venous blood samples were run through
the blood-gas analyzer for SvO2-blood measurements.
|
|
Measurements on human subjects.
We performed measurements on eight healthy human subjects (6 men and 2 women; mean age of 24.5 yr, age range of 20-35 yr). The subjects
sat on a comfortable chair and rested for 10-15 min before the
experimental protocol was started. A pneumatic cuff was placed around
the right thigh of the subject to later induce a venous occlusion by
inflating the cuff to a pressure of 70 mmHg. A pulse oximeter probe
(Nellcor, N-200) was placed on the index finger of the left hand. A
strain-gauge belt (Sleepmate/Newlife Technologies, Resp-EZ) was
placed around the subject's upper abdomen to monitor the
respiratory excursion. As in the piglet experiment, we used the analog
outputs of the pulse oximeter and strain gauge for continuous
coregistration of the physiological and near-infrared data. Two optical
probes were placed on the right thigh; the first probe (probe
HVM) was positioned on top of a visible superficial vein of the
vastus medialis muscle, and the second probe (probe HVL) was
placed on the vastus lateralis muscle, far from visible superficial
veins. During the measurements, we asked the subject to breathe
regularly, following a metronome whose frequency was set to the average
breathing rate of the subject at rest (typically 14-15
breaths/min). During the whole experiment, the subject was asked to
breathe at the same frequency as the metronome pace. No subjects
experienced any discomfort or difficulties with this procedure. The
measurement protocol consisted of 2 min of baseline (we acquired 1,535 optical data points at 80 ms/point), followed by 40 s of venous
occlusion, and a final recovery period of a few minutes. A few subjects
performed an additional exercise routine to test the effect of exercise
on the measured value of SvO2-NIRSresp on
the muscle. The exercise consisted of raising the right foot, voluntarily contracting the leg muscles (isometric contraction), until
the subject felt tired. The human study was approved by the
Institutional Review Board of Tufts University, where the human
experiments were performed; all subjects gave their written, informed consent.
Near-infrared data processing for the measurement of
SvO2.
We used a modified Beer-Lambert law approach (14) to
translate the temporal intensity ratio collected at each wavelength [I(
, t)/I(
, 0), where
I is intensity,
is wavelength, and t is
time] at a distance of 1.0 cm from the illumination point, into a time variation in the tissue absorption
[
µa(
, t), where
µa is the tissue absorption coefficient].
This approach was implemented by applying the following equation
(14)
|
(1)
|
where Leff is the effective optical
pathlength from the illuminating point to the light collection point.
We measured Leff by quantifying
µa and the reduced scattering coefficient (µ's) using the frequency-domain
multidistance method (17). The diffusion-theory
relationship that gives Leff in terms of
µa,
µs', and the source-detector separation (r) in a semi-infinite turbid medium (where the
illumination and collection points are at the boundary of the turbid
medium) is the following (17)
|
(2)
|
More details on this hybrid frequency-domain [to measure
Leff(
)] and continuous wave (modified
Beer-Lambert law) approach are given in Refs. 14,
17, 21, and 22. Equation 2
shows that for typical values of the near-infrared
µa and µ's, say µa = 0.1 cm
1 and
µ's = 10 cm
1, the
value of Leff is ~5.5 cm for r = 1 cm. The multi-distance scheme was implemented by considering the
data collected by the two fiber bundles located at two different
distances (1.0 and 2.0 cm) from the source fiber bundle. At these
source detector distances, the diffusion regime of light propagation in
tissues is already established (18). As an alternative to
the diffusion equation model to describe the spatial dependence of the
optical signal, empirical approaches have been proposed
(6). The different sensitivity of the two detector
channels was accounted for by a preliminary calibration measurement on
a synthetic tissue-like sample. The applicability of the initial
calibration to the whole data set was verified at the end of each
measurement session by repositioning the optical probe on the
calibration sample. We typically reproduced the calibration values of
the block optical coefficients to within 10%. In the piglet
experiments, we updated the measured values of
Leff at each wavelength every time the FIO2 was changed. Specifically,
Leff was computed, according to Eq. 2, from average measurements of µa and
µ's over the last 80 s of each
period corresponding to a specific FIO2
value. For the measurements on human subjects, we computed an initial
value of Leff (at each wavelength) over the
first 2 min of baseline, and we used this value for the analysis of the data over the whole measurement session. The long integration time for
the mean pathlength measurements (80 s in the piglet experiment,
120 s in the human subjects measurements) realized a low-pass
filter that minimized the time-varying contributions from the Hb
oscillations caused by the arterial pulsation and breathing.
Furthermore, the two-distance measurement scheme for the mean
pathlength measurement also provided some level of spatial averaging.
In contrast, the optical data for the measurement of SvO2 were acquired with an 80-ms temporal resolution
and with the use of a single source-detector distance (1 cm).
To measure the SvO2, we followed a two-step procedure.
First, we computed the amplitude of the absorption oscillations at the
respiratory frequency at each of the eight wavelengths considered. Second, we fit the spectrum of the experimental absorption
amplitude with the hemoglobin absorption spectrum. We have used two
alternative methods to quantify the absorption oscillations at the
respiratory frequency. The first method is based on the fast Fourier
transform (FFT) of
µa(t). The
sum of the amplitudes of the FFT of
µa over
the respiratory frequency band yields a measure of the amplitude of the
respiration-induced absorption oscillations. This method assumes that
the Fourier spectrum of
µa clearly shows a
discernable peak at the respiratory frequency. The second method is
based on a band-pass (BP) filter of
µa(t) and on a modeling
algorithm (MA) (sine-wave fit). The BP filter serves the purpose of
isolating the absorption oscillations at the respiratory frequency by
suppressing higher and lower frequency components in
µa(t). The MA consists of
fitting a sine wave to
µa(BP) over each
respiratory cycle. The amplitude of the fitted sine wave gives an
estimate of the absorption oscillation amplitude at the respiratory
frequency. As a result, the second method (BP + MA) achieves a
reading of SvO2 from each individual respiration
cycle, whereas the first method (FFT) requires multiple respiration
cycles to produce a SvO2 reading. Both methods provide phase readings that can be used to verify that the respiration-induced absorption oscillations at different wavelengths are in phase with each
other. We indicate the SvO2 measurement according to the FFT and BP + MA methods with
SvO2-NIRSresp(FFT) and
SvO2-NIRSresp(BP), respectively.
In the piglet experiments, we evaluated the FFT of
µa over 256 data points, corresponding to a
time trace of 20.5 s, to achieve reliable spectra from a number of
breathing periods (typically 13-16). Furthermore, we averaged
about 800 successive FFTs (each computed from a data set shifted by one
data point with respect to the previous one), so that the total number
of data points resulting in a single SvO2 reading was
on the order of 1,000, corresponding to a train of data 80 s long.
This 80-s-long data set was chosen to be at the end of each
FIO2 period, and it coincides with the
80-s period over which we measured Leff. In the
human subject experiment, we used 512 points for the FFT because the
breathing frequency was lower (0.22-0.26 Hz) than that of the
piglets (0.6-0.9 Hz) and we wanted to have a similar number of
breathing periods. As in the piglets experiment, we averaged the
results from multiple (500-1,000) successive FFTs.
The spectrum of the amplitude of the absorption oscillations at the
respiratory frequency
[
µ
(
i)] was fitted with a linear combination of the HbO2 and Hb
extinction spectra,
HbO2(
i)
[HbO2]resp +
Hb(
i)
[Hb]resp,
where
HbO2(
i) and
Hb(
i) are the extinction
coefficients of HbO2 and Hb, respectively (43,
53). The fitting parameters were the amplitudes of the
oscillatory concentration of oxyhemoglobin
(
[HbO2]resp) and deoxyhemoglobin
(
[Hb]resp) at the respiratory frequency. The
minimization of the sum of the squares of the residuals, i.e.,
i[
µ
(
i)
µ
(
i)]2,
yields a linear system whose solution gives the following best fit
concentrations of amplitude of the oscillatory [HbO2] and [Hb] (11)
|
(3)
|
|
(4)
|
The oxygen saturation of the hemoglobin compartment oscillating
synchronously with respiration
(SvO2-NIRSresp) is then given by
|
(5)
|
It is important to note that for the determination of
SvO2-NIRSresp one only needs to know
Leff to within a wavelength-independent factor.
In fact, Eq. 5 shows that a common, wavelength-independent multiplicative factor in
µa(
i) cancels out in the expression for SvO2-NIRSresp. In
contrast, the wavelength dependence of Leff is
important for the measurement of SvO2 with our method,
and this is why we have opted to measure Leff at
each wavelength using the multidistance, frequency-domain technique. It
is also important to observe that our method requires 1)
oscillations of µa at the respiratory
frequency to be reliably attributed to hemoglobin (and not, for
instance, to motion artifacts), 2) the hemoglobin
concentration fluctuations to result from the volume oscillation of a
hemoglobin compartment rather than from periodic fluctuations in the
blood flow, and 3) the fluctuating hemoglobin compartment
responsible for the measured
µa to be
mainly the venous compartment. In our measurements, we have considered each one of the three above points. The assignment of the absorption oscillations to hemoglobin (point 1) was done by requiring
that the hemoglobin spectrum fits the absorption data relatively well. To this aim, we requested that the average absolute value of the relative residuals, defined as
fit = 1/N
|
µ
(
i)
µ
(
i) | /
µ
(
i), where N is the number of wavelengths considered, be at most
twice the experimental percent error in
µ
. We also used the standard
deviation of the SvO2-NIRSresp(FFT) values
obtained with the 800 (piglet experiment) or 500-1,000 (human
experiment) successive FFTs to estimate the error in
SvO2-NIRSresp(FFT). We discarded the cases
having a standard deviation error in
SvO2-NIRSresp greater than 15%. The
assignment of the absorption oscillations to volume rather than blood
flow fluctuations (point 2) is achieved by verifying that
the absorption oscillations at the eight wavelengths are in phase. In
fact, blood flow fluctuations induce out-of-phase oscillations in the
[HbO2] and [Hb] (because of the increased rates of
inflow of HbO2 and washout of Hb), as opposed to the in-phase oscillations of HbO2 and Hb that result from
volume pulsations. The third point, namely the requirement that the
absorption oscillations at the respiratory frequency are representative
of venous blood, is investigated by 1) comparing the
SvO2-NIRS from the respiratory hemoglobin oscillations
(SvO2-NIRSresp) with the corresponding values measured by gas analysis of SvO2-blood (piglet
experiments) or by the NIRS venous occlusion method
(SvO2-NIRSvo) (human subject experiments),
2) studying the effect on the [Hb] and
[HbO2] oscillations at the respiratory frequency of a
venous occlusion induced between the lungs and the peripheral
measurement area (the thigh muscles in human subject experiments), and
3) by recording the effect of muscle exercise on the
near-infrared measurements of SvO2
[SvO2-NIRSresp(BP)] in human subjects.
 |
RESULTS |
Figure 4 reports average spectra of
Leff measured for a source-detector separation
of 1 cm. Figure 4A refers to piglet measurements conducted
at two different values of FIO2, whereas
Fig. 4B refers to human measurements with probes
HVM and HVL. The error bars in Fig. 4 represent the
standard deviations over multiple measurements (multiple
FIO2 cycles and piglets for Fig.
4A and multiple subjects for Fig. 4B).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Near-infrared spectra of the effective optical pathlength
(Leff) measured on the piglet's leg
(A) and a human thigh muscle (B) for a
source-detector separation (r) of 1 cm. In A,
different symbols refer to 2 different values of
FIO2. In B, different symbols
refer to 2 different thigh muscles (vastus medialis for probe
HVM and vastus lateralis for probe HVL). The lines join
the points as an aid to the eye.
|
|
In the piglet experiment, we discarded 11 (from a total of 67)
SvO2-NIRSresp(FFT) measurements because
the standard deviation over 800 FFTs exceeded 15%. These discarded
SvO2-NIRSresp(FFT) readings occurred as
follows: one (of 8) in piglet 1, two (of 26) in piglet
2, and eight (of 33) in piglet 3. One discarded reading
was assigned to motion artifacts, whereas the other ten discarded
measurements all occurred at low-FIO2
values (10-17.5%) corresponding to SvO2-blood
values of 20-50%. We were not able to apply the BP method to
piglet 2 and to the FIO2
cycles A and B of piglet 3 because of
irregular absorption oscillation waveforms that were not reliably
processed by the BP + MA approach.
Figure 5 shows typical temporal traces of
the relative [HbO2] and [Hb] measured on the piglet's
leg (with optical probe PR) (Fig. 5A) and on the
human vastus medialis muscle at rest (Fig. 5B) and during
venous occlusion on the upper thigh (optical probe HVM)
(Fig. 5C). The temporal traces of [Hb] and
[HbO2] are obtained by fitting the measured spectrum of
µa(
,t) (whose value at each
wavelength was obtained from Eq. 2) with a linear
combination of the HbO2 and Hb extinction spectra. This
procedure results in the application of Eqs. 3 and 4 without the superscript "resp" on
µa,
[HbO2], and
[Hb].
Two oscillatory components are clearly visible in the relative
[HbO2] and [Hb] traces of Fig. 5A: the first
one, associated with the heartbeat (as shown by the pulse oximeter
data; top trace in Fig. 5) is at a frequency of ~2.5 Hz, whereas the
second one, associated with respiration (as shown by the strain gauge
signal; second trace from the top in Fig. 5), is at a frequency of
~0.65 Hz. Only the latter oscillatory component (at a frequency of
~0.23 Hz in human subjects) is clearly visible in Fig. 5B,
whereas neither is present in Fig. 5C. Figure 5,
B and C, shows additional low-frequency
oscillations associated with changes in blood pressure and heart rate.
We observe that the strain-gauge signal (second trace from the top in
Fig. 5) increases during inspiration and decreases during expiration. The BP filter described in the previous section aims at isolating the
oscillatory component at the respiratory frequency by filtering out
higher and lower frequency components. The relative
[HbO2] and [Hb] traces after BP filtering are shown in
Fig. 5, bottom. In the case reported in Fig. 5, which is
representative of the results reported in this article for
SvO2-NIRSresp, the oscillatory components
of [HbO2] and [Hb] at the respiratory frequency are in
phase with each other and disappear during venous occlusion.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 5.
Representative traces of the relative HbO2
concentrations ([HbO2]) and Hb concentrations ([Hb])
measured on the piglet's leg (with optical probe PR)
(A) and on the human vastus medialis muscle at rest
(B) and during venous occlusion on the upper thigh (optical
probe HVM) (C). Bottom panels report
the [Hb] traces after processing with the digital band-pass filter
[band pass (BP) + modeling algorithm (MA)] designed to isolate
the oscillations at the respiratory frequency. Top trace
represents the piglet's heartbeat monitored by the pulse oximeter.
Second trace from the top is the strain gauge signal that
monitors the respiratory excursion. The strain gauge signal increases
during inspiration and decreases during expiration. a.u., Arbitrary
units.
|
|
Figure 6 illustrates representative
µ
spectra measured on the
piglet's leg (probe PR) (Fig. 6A) and on the
human vastus medialis muscle at rest (Fig. 6B) and during
venous occlusion on the upper thigh (probe HVM) (Fig. 6C). The y-axis of each panel of Fig. 6 refers to
the values of
µ
obtained with the
BP filter method. The values of
µ
computed with the FFT method are normalized by a wavelength-independent factor to match the BP value of
µ
at 636 nm. The relatively high value of
fit
during venous occlusion (Fig. 6C) is an indication of the
poor fit, which in turn results from the lack of hemoglobin
oscillations at the respiratory frequency (see Fig. 5C,
bottom, and the y-axis values of Fig.
5C compared with those of Fig. 5B).
Figure 6 also shows the best fit of the hemoglobin absorption spectrum
to the BP
µ
and to the FFT
µ
. The best-fit hemoglobin spectra
represent the oxygen saturation of hemoglobin, as illustrated in Fig.
1. The value of SvO2-NIRSresp is given by
Eq. 5.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Representative change in respiratory tissue absorption
coefficient ( µ ) spectra measured with the BP
and fast Fourier transform (FFT) methods on the piglet's leg
(probe PR) (A) and on the human vastus medialis
muscle at rest (B) and during venous occlusion on the upper
thigh (probe HVM) (C). The experimental 8-point
µ spectra were fitted with the hemoglobin
absorption spectrum (with the oxy- and deoxyhemoglobin concentrations
as fitting parameters). The values of fit (defined in
the text) for the BP and FFT spectra give a measure of the quality of
the fit.
|
|
Figure 7 compares the measurements of
SvO2-NIRSresp(BP),
SvO2-NIRSresp(FFT), and
SvO2-blood during cycle A of piglet
1 and during cycle C of piglet 3. The
SvO2-NIRSresp(BP) traces reported in Fig.
7 were obtained by performing a running average of the breath-to-breath
values obtained with the BP method. In Fig. 7, the averaging procedure
consists of a 5-point (in Fig. 7A) or 15-point (in Fig.
7B) running average. The assessment of the agreement between
the measurements of SvO2-NIRSresp(FFT) and
SvO2-blood in the full piglet study is carried out
according to the procedure described by Bland and Altman
(5). Figure 8A
plots the results of the NIRS method based on the respiratory
oscillations of the tissue absorption against the invasive measurement
of SvO2-blood. The shape of the symbols in Fig.
8A indicates the piglet number, whereas the type of fill
indicates the location of the NIRS measurement. The range of
SvO2-blood values considered in this study is
~20-95%. The error bars in Fig. 8A are the standard
deviations (SD) computed from the results of ~800 successive FFTs (as
described in MATERIALS AND METHODS). Figure 8B
displays the difference between the two readings vs. their average, and
it quantifies the discrepancy between the two methods and the possible
dependence of such a difference on the level of SvO2.
The mean difference between SvO2-NIRSresp and SvO2-blood over the full oxygenation range
considered in this study is 1.0% (a measurement of the bias of the
SvO2-NIRSresp measurement), and the SD of
the difference is 5.8%. Figure 8B does not show any
striking dependence of the difference on the mean. If we take the
values of mean difference ± 2 SD as the limits of agreement of
the two methods (5), we get an estimate of the maximal
discrepancies between SvO2-NIRSresp(FFT)
and SvO2-blood of
10.6% and +12.6%.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Comparison between the continuous measurement of
SvO2-NIRSresp (BP) and the discontinuous
measurements of SvO2-NIRSresp(FFT) and
SvO2-blood. A refers to cycle A
of piglet 1, whereas B refers to cycle
C of piglet 3. The values of
FIO2 (%, left y-axes)
during the experiment are indicated by the shaded profiles.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 8.
Comparison of SvO2-NIRSresp (FFT) and
SvO2-blood in the piglet study. The shape of the
symbols refer to the piglet (circles, piglet 1; squares,
piglet 2; triangles, piglet 3), whereas the
filling indicates the measurement side (filled symbols, right leg,
i.e., probe PR; open symbols, left leg, i.e., probe
PL). A: SvO2-NIRSresp(FFT)
is plotted vs. SvO2-blood. B: difference is
plotted vs. the average of the 2 measurements. Two horizontal lines
indicate the range given by mean difference ± 2 SD (SD is the
standard deviation of the difference between the 2 measurements).
|
|
In the human experiment, we found that the NIRS values of
SvO2 measured with probe HVM (placed on top
of a visible vein) were typically smaller than those measured with
probe HVL (placed far from any visible vein). Furthermore,
the amplitude of the oscillatory absorption at the respiration
(heartbeat) frequency was typically greater (smaller) for the data
collected with probe HVM than with probe HVL. Of
the 16 SvO2-NIRSresp measurements (8 subjects, 2 locations), we discarded only 2 measurements (because of a
value of
fit greater than twice the error in
µ
), both collected with
probe HVL. Figure 9 compares
the SvO2-NIRSresp values measured in the
human subjects at rest in which the FFT method and the BP filtering
approach were used. Figure 9A shows the good agreement of
the two measurements, and Fig. 9B quantifies the average
difference (0.9%) and the maximum discrepancies of
5.1 and +6.9%,
as given by the mean ± 2 SD of the differences. Figure
10 reports a similar comparison between
SvO2-NIRSresp(FFT) and
SvO2-NIRSvo. As described by Yoxall and
Weindling (56), under the assumption that a venous
occlusion induces an initial increase in the venous blood volume,
SvO2-NIRSvo is given by
[H
O2]0/[H
T]0,
where the dots indicate a time derivative and the subscript 0 indicates
the initial time that immediately follows the onset of venous
occlusion. The agreement between
SvO2-NIRSresp(FFT) and
SvO2-NIRSvo is good, with an average
deviation of 0.8% and maximum discrepancies of
4.2 and +5.8%. Two
horizontal lines in Figs. 8B and 9B indicate the
range given by the mean difference ± 2 SD. The maximum
discrepancy among SvO2-NIRSresp(FFT),
SvO2-NIRSresp(BP), and
SvO2-NIRSvo is less than the maximum
deviation between SvO2-NIRSresp(FFT) and
SvO2-blood found in piglets (see Fig. 8B).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 9.
Comparison of SvO2-NIRSresp (FFT) and
SvO2-NIRSresp(BP) in the human study.
, Vastus medialis muscle; i.e., probe
HVM. , Vastus lateralis muscle; i.e.,
probe HVL. Probe HVM was place on top of a
visible superficial vein, whereas probe HVL was
far from visible veins. A:
SvO2-NIRSresp(FFT) is plotted vs.
SvO2-NIRSresp(BP). B:
difference is plotted vs. the average of the 2 measurements. Two
horizontal lines in B indicate the range given by mean
difference ± 2 SD.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 10.
Comparison of SvO2-NIRSresp (FFT) and
SvO2-NIRSvo (venous occlusion) in the
human study. , Vastus medialis muscle; i.e.,
probe HVM. , Vastus lateralis muscle; i.e.,
probe HVL. Probe HVM was place on top of a
visible superficial vein, whereas probe HVL was far from
visible veins. A:
SvO2-NIRSresp(FFT) is plotted vs.
SvO2-NIRSvo. B: difference is
plotted vs. the average of the 2 measurements. Two horizontal lines in
B indicate the range given by mean difference ± 2 SD.
|
|
The effect of muscle exercise on the measurement of
SvO2-NIRSresp(BP) on top of a visible
superficial vein (probe HVM) is illustrated in Fig.
11. Although SaO2
(measured with a pulse oximeter) is unaffected by the exercise,
SvO2-NIRSresp(BP) shows a significant postexercise decrease from a baseline value of 75-78% down to a
minimum value of ~54%. The recovery to the baseline value of SvO2-NIRSresp(BP) occurs after ~30 s. By
using the BP approach, we could monitor
SvO2-NIRSresp at every breathing period,
i.e., every ~5 s, thus achieving a real-time monitoring of
SvO2. We observe that we could not obtain meaningful
measurements of SvO2-NIRSresp during
exercise because of motion artifacts.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 11.
Continuous measurement of
SvO2-NIRSresp(BP) with optical probe
HVM (vastus medialis muscle, on top of a visible superficial vein)
on a healthy human subject during baseline and after isometric muscle
exercise (recovery).
|
|
 |
DISCUSSION |
Various methods for measuring SvO2.
The method presented in this article to measure SvO2
from the near-infrared absorption oscillations at the respiratory
frequency (spiroximetry) can be implemented by using a FFT or a digital BP filter in conjunction with a MA. We have indicated the measurements of SvO2 obtained with these two approaches with the
notations SvO2-NIRSresp(FFT) and
SvO2-NIRSresp(BP), respectively. An
alternative method for measuring SvO2 with NIRS is
based on a previously described venous occlusion protocol (13,
39, 55, 56). We have identified the results of this measurement
procedure with the notation SvO2-NIRSvo. In the human study, the NIRS measurements were conducted at two locations on the thigh. One location was on top of a visible
superficial vein of the vastus medialis muscle (probe HVM),
and the second location was far from visible superficial veins on the
vastus lateralis muscle (probe HVL). Finally, the invasive
measurement of SvO2 performed by the gas analysis of
venous blood samples is indicated with SvO2-blood. In
this section, we discuss the different features of these measurements
of SvO2, and the comparison of their results, as
reported in Figs. 7-9.
The FFT and BP filter approaches to near-infrared spiroximetry.
The major advantage of the BP approach is that it allows for a
real-time measurement of SvO2 by providing a reading
of SvO2-NIRSresp(BP) at every respiration
cycle. Consequently, this method is particularly effective during
transients, as illustrated by the recovery of the
SvO2-NIRSresp(BP) traces corresponding to
the sudden increase of FIO2 to 100% in
piglets (see Fig. 6, A and B), or to the end of
the exercise period in human subjects (see Fig. 11). On the other hand,
the BP filter + MA method is susceptible to fluctuations in the
respiratory frequency and to irregular respiration patterns. This
accounts for the fact that we did not get reliable readings of
SvO2-NIRSresp(BP) in piglet 2 and in FIO2 cycles A and
B of piglet 3. The FFT method was more robust,
producing reliable readings in 56 of 67 cases (84%) in the piglet
study and in 14 of 16 cases (87%) in the human study. It is important
to observe that 10 of the 11 discarded readings in piglets occurred at
low-SvO2-NIRS-blood values (20-50%), and one was
assigned to motion artifacts. Both discarded readings in the human
study were collected with probe HVL, which was placed far
from visible veins. Therefore, we have found indications that the
measurement of SvO2-NIRSresp(FFT) is particularly robust at SvO2 values >50% (in piglets)
and when the optical probe is placed on top of a visible superficial
vein (in human subjects). Although the FFT method, which is based on a
measurement of the integrated peak at the respiratory frequency, is
less sensitive than the BP method to irregular respiration patterns, it
is not applicable during transients. In fact, we did not obtain
reliable readings of SvO2 when the time frame used to
compute SvO2-NIRSresp(FFT) (80 s in
piglets, 80-120 s in human subjects) included significant changes
in the SvO2. When both the FFT and the BP methods can
be applied, they provide SvO2-NIRSresp measurements that are in excellent agreement, as shown in Figs. 6 and
9. The differences between the two measurements (SD of 3.0%) are
comparable with measurement errors and significantly less than the
maximum deviation between
SvO2-NIRSresp(FFT) and
SvO2-blood (approximately ±10%) observed in the
piglet study (see Fig. 8B).
Measurements of SvO2-NIRSresp and
SvO2-NIRSvo.
Both of these NIRS methods to measure the SvO2
(resp and vo) rely on a change in the volume fraction of venous blood
in the tissue. The two major differences between the two methods are as
follows. 1) The vo method requires an external perturbation consisting of a pneumatic-cuff-induced venous occlusion, whereas the
resp method is only based on the intrinsic blood pressure oscillations
induced by normal respiration and can be applied continuously.
2) The vo method can be applied only to limbs, whereas the
resp method can, in principle, be applied to any tissue and in
particular to the brain, as already shown by Wolf et al.
(52). However, we stress that it is always important to
verify that the [HbO2] and [Hb] oscillate in phase at
the respiratory frequency for the resp method to provide reliable
measurements of SvO2. For instance, Elwell et al.
(16) reported out-of-phase oscillations of [Hb] and
[HbO2] in the human brain, which would indicate a blood
flow rather than volume oscillations, thus rendering the resp method
inapplicable. In our human study, we found an excellent agreement
between SvO2-NIRSresp(FFT) and
SvO2-NIRSvo, with a maximum deviation on
the order of ±4-5% (see Fig. 10).
Optical probes PR, PL, HVM, and HVL.
In the piglet study, we have found no significant difference
between the SvO2-NIRSresp(FFT) data
collected with probes PR (on the right leg) and
PL (on the left leg, where the venous catheter was inserted)
(see Fig. 8A). This result indicates that noninvasive measurements of SvO2 on one leg can be meaningfully
compared with invasive measurements of SvO2 on the
other leg. In the human study, we found some differences between the
SvO2-NIRS measurements with probe HVM
(placed on top of a visible superficial vein in the vastus medialis
muscle) and with probe HVL (placed far from visible veins on
the vastus lateralis muscle). As shown in Figs. 8 and 9, the
SvO2-NIRS readings (with both the NIRSresp
and NIRSvo method) of probe HVM (see Figs. 8 and
9) were typically smaller than the readings of probe HVL
(see Figs. 8 and 9). We assign this result to a partial contribution
from the capillary and/or arterial compartments picked up by
probe HVL. In fact, although the optical data from probe HVM
shown in Fig. 4, B and C, do not show any visible
contribution from the arterial pulsation, data from probe
HVL (not shown) do contain pulsatile components at the heartbeat
frequency. As a result, we believe that the optical probe should be
placed on top of visible superficial veins for more accurate readings
of SvO2-NIRSresp on human subjects. We
believe that the reason that SvO2-NIRSresp
readings in the piglet study were in close agreement with the invasive
measurement of SvO2, despite the evident arterial pulsation in Fig. 5A, is related to the smaller extent of
respiratory sinus arrhythmia in piglets with respect to humans. In
fact, respiratory sinus arrhythmia is the main origin of the arterial
oscillations at the respiratory frequency (38). The larger
role played by respiratory sinus arrhythmia in human subjects with
respect to piglets will probably require a more careful interpretation
of the optical data for spiroximetry. However, the results of Fig. 11
show the practical applicability of spiroximetry to human subjects, so
that we do not expect respiratory sinus arrhythmia to introduce an
intrinsic limitation of the method.
Noninvasive vs. invasive measurements of SvO2.
The comparison between
SvO2-NIRSresp(FFT) and
SvO2-blood in the piglet study shows a maximum
deviation range of
10.6% to +12.6%. The local character of the
SvO2 (as opposed to the systemic nature of the
SaO2) requires some caution in the comparison of invasive (SvO2-blood) and noninvasive
(SvO2-NIRS) measurements of SvO2. In
fact, in our piglet study, SvO2-blood was measured from blood samples drawn from the femoral vein, whereas
SvO2-NIRSresp was measured with an optical
probe placed on the leg muscle. It is likely that the NIRS oscillatory
signal (at the respiratory frequency) is not just representative of the
femoral vein and may therefore be indicative of the oxygen consumption
at different tissue areas than those affecting the femoral vein
saturation. This fact may not lead to significant differences under
rest conditions, but it may be important under stress. Although we
found a good agreement between
SvO2-NIRSresp(FFT) and
SvO2-blood over the whole range of
FIO2 values considered (see Fig. 8), we
observed a meaningfully greater SD of the differences over the
20-55% SvO2-blood range (SD = 7.8%) than
in the 55-95% range (SD = 3.6%).
Effect of muscle exercise on
SvO2-NIRSresp(BP).
The result reported in Fig. 11 serves the purpose of further
illustrating the potential of the
SvO2-NIRSresp(BP) measurement approach. In
fact, Fig. 11 shows the feasibility of monitoring the
SvO2 in real time on a breath-to-breath basis (one
data point every 4-5 s). Furthermore, the baseline
SvO2-NIRSresp(BP) value of 75-78%
and the exercise-induced drop indicate the venous origin of the
saturation measurement, since the SaO2 measurement
provided by the pulse oximeter stayed constant at 98 ± 1% for
the whole measurement period. On the other hand, Fig. 11 reports only
one representative case, and more studies are required to quantify the
effect of muscle exercise on the measurement of
SvO2-NIRSresp.
In conclusion, we have presented a noninvasive approach to
measure the SvO2 in tissues from the near-infrared
spectrum of the amplitude of respiration-induced absorption
oscillations. We have implemented this approach, which we call
near-infrared spiroximetry, by processing the optical data with a FFT
method or with a digital BP filter in conjunction with a MA. More
sophisticated data processing schemes may further improve the
effectiveness and the range of applicability of spiroximetry. The
SvO2 measurements reported in this article complement
previously demonstrated NIRS measurements of
StO2 (8, 27) and
SaO2 (21). Therefore, our results may
lead to the design of a noninvasive optical instrument capable of
providing simultaneous and real-time measurements of local
SaO2, StO2, and
SvO2.
We thank Aradhana Arora, Matthew Hoimes, and Tanya Fridman
for technical assistance during the preliminary measurements on human
subjects and Dennis Hueber and Valentina Quaresima for helpful discussions. We also thank Enrico Gratton for lending us the
eight-wavelength laser board used in this study. We are grateful to the
volunteers who participated in this study.
This research is supported by the National Institutes of Health Grants
R01-MH-62854 (to M. A. Franceschini) and R29-NS-38842 (to D. A. Boas) and by the US Army Awards DAMD17-99-2-9001 (to D. A. Boas) and DAMD17-99-1-9218 (to S. Fantini). D. A. Boas
acknowledges financial support from the Center for Innovative Minimally
Invasive Therapies.
The material presented does not necessarily reflect the position or the
policy of the U.S. Government, and no official endorsement should be inferred.
Address for reprint requests and other correspondence: M. A. Franceschini, Bioengineering Center, Dept. of Electrical Engineering and Computer Science, Tufts Univ., 4 Colby St., Medford, MA 02155-6013 (E-mail: mari{at}eecs.tufts.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 24 May 2001; accepted in final form 20 August 2001.